Literature DB >> 8903219

Molecular epidemiology of Pneumocystis carinii pneumonia.

C B Beard1, T R Navin.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8903219      PMCID： PMC2639819          DOI： 10.3201/eid0202.960214

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


× No keyword cloud information.
  24 in total

Review 1.  Laboratory diagnosis of pneumocystosis.

Authors:  J W Smith; M S Bartlett
Journal:  Clin Lab Med       Date:  1991-12       Impact factor: 1.935

2.  Penicillin and trimethoprim-sulfamethoxazole-resistant pneumococci isolated from blood cultures of three infants in Metropolitan Washington, DC: a harbinger of serious future problems?

Authors:  R H Schwartz; W N Khan; S Akram
Journal:  Pediatr Infect Dis J       Date:  1991-10       Impact factor: 2.129

3.  Activation and transmission in rats of infection with Pneumocystis.

Authors:  J O Hendley; T H Weller
Journal:  Proc Soc Exp Biol Med       Date:  1971-09

4.  A natural source of infection due to pneumocystis carinii.

Authors:  W T Hughes; D L Bartley; B M Smith
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226

5.  Protein-calorie malnutrition. A host determinant for Pneumocystis carinii infection.

Authors:  W T Hughes; R A Price; F Sisko; W S Havron; A G Kafatos; M Schonland; P M Smythe
Journal:  Am J Dis Child       Date:  1974-07

Review 6.  Is Pneumocystis carinii a deep mycosis-like agent?

Authors:  E Dei-Cas; J C Cailliez; F Palluault; E M Aliouat; E Mazars; B Soulez; J Suppin; D Camus
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

7.  Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.

Authors:  R A Torres; M Barr; M Thorn; G Gregory; S Kiely; E Chanin; C Carlo; M Martin; J Thornton
Journal:  Am J Med       Date:  1993-12       Impact factor: 4.965

8.  Detection of Pneumocystis carinii with DNA amplification.

Authors:  A E Wakefield; F J Pixley; S Banerji; K Sinclair; R F Miller; E R Moxon; J M Hopkin
Journal:  Lancet       Date:  1990-08-25       Impact factor: 79.321

9.  Latency is not an inevitable outcome of infection with Pneumocystis carinii.

Authors:  W Chen; F Gigliotti; A G Harmsen
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

10.  The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group.

Authors:  J Phair; A Muñoz; R Detels; R Kaslow; C Rinaldo; A Saah
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245
View more
  2 in total

1.  Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission.

Authors:  C B Beard; J L Carter; S P Keely; L Huang; N J Pieniazek; I N Moura; J M Roberts; A W Hightower; M S Bens; A R Freeman; S Lee; J R Stringer; J S Duchin; C del Rio; D Rimland; R P Baughman; D A Levy; V J Dietz; P Simon; T R Navin
Journal:  Emerg Infect Dis       Date:  2000 May-Jun       Impact factor: 6.883

2.  The Prevalence of Pneumocystis jiroveci in Bronchoalveolar Lavage Specimens of Lung Transplant Recipients Examined by the Nested PCR.

Authors:  Morteza Izadi; Nematollah Jonaidi Jafari; Javid Sadraei; Abbas Mahmoodzadeh Poornaki; Babak Rezavand; Hossein Zarrinfar; Jahangir Abdi; Younes Mohammadi
Journal:  Jundishapur J Microbiol       Date:  2014-12-01       Impact factor: 0.747
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.